Citra Buana Prasida Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Citra Buana Prasida Tbk. trades at Rp535 (market cap 725.59B, 295.9K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Citra Buana Prasida Tbk. is far larger — about 2.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Citra Buana Prasida Tbk. is more actively traded (295.9K versus 41.7K). Which is the better fit depends on your goals.
| CBPE | DGNS | |
|---|---|---|
Market Cap | 725.59B | 316.25B |
Volume | 295.9K | 41.7K |
Lot | 2.96K | 417 |
Turnover | 165.79M | 9.66M |
Average Price | 560.28 | 231.65 |
Value | 165.79M | 9.66M |
Indicative Equilibrium Price | 580 | 230 |
Indicative Equilibrium Volume | 526 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Buana Prasida Tbk Entity which was originally named PT Prasetia Sejati was established on August 24, 2000 based on the Deed of Establishment No. 18, drawn up in the presence of Ninik Sukadarwati, SH., Notary of the Bekasi Regency Level II, in Tambun. The Entity started its commercial business in 2005.
Read more on CBPE →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →